Thursday, November 12, 2020 Daily Archives

Hiring staff ‘extra challenging’ during pandemic, says Emergent VP

by

Emergent tries to fill bioprocessing talent gaps as it works to meet COVID-19 manufacturing demand. When the pandemic hit earlier this year, Emergent Biosolutions found its services as a specialist in vaccine development and manufacturing sought after by a number of leading efforts against COVID-19. The company’s contract development and manufacturing organization (CDMO) business unit found itself well placed, having already built up its capacity specifically to counter a pandemic alongside the US government. Alongside its newly found popularity as…

November 12, 2020

Hyasynth harnesses biopharma processes bringing yeast-made CBD to market

by

Using yeast fermentation in a similar way to insulin synthesis provides a cheaper, more sustainable way to make cannabinoids like CBD, says Hyasynth. Last month, Canadian firm Hyasynth received a $2.5 milllion milestone payment for its commercialization achievements in being first-to-market with cannabidiol (CBD) produced and extracted from a biomanufacturing setup. “It’s a typical yeast fermentation, so the equipment involved would be similar to the production of insulin,†Kevin Chen, CEO of Hyasynth told this publication. “We grow the yeast…

November 12, 2020